Jenny R. Robertson
2023
In 2023, Jenny R. Robertson earned a total compensation of $1.3M as Chief Business and Legal Officer at Lexeo Therapeutics, a 22% increase compared to previous year.
Compensation breakdown
| Non-Equity Incentive Plan | $204,000 |
|---|---|
| Option Awards | $678,734 |
| Salary | $402,500 |
| Other | $11,400 |
| Total | $1,296,634 |
Robertson received $678.7K in option awards, accounting for 52% of the total pay in 2023.
Robertson also received $204K in non-equity incentive plan, $402.5K in salary and $11.4K in other compensation.
Rankings
In 2023, Jenny R. Robertson's compensation ranked 931st out of 2,978 executives tracked by ExecPay. In other words, Robertson earned more than 68.7% of executives.
| Classification | Ranking | Percentile |
|---|---|---|
All | 931 out of 2,978 | 69th |
Division Manufacturing | 549 out of 1,637 | 67th |
Major group Chemicals And Allied Products | 373 out of 906 | 59th |
Industry group Drugs | 362 out of 869 | 58th |
Industry Biological Products, Except Diagnostic Substances | 110 out of 211 | 48th |
Source: SEC filing on April 26, 2024.
Robertson's colleagues
We found three more compensation records of executives who worked with Jenny R. Robertson at Lexeo Therapeutics in 2023.